Skip to main content

Table 2 Geographic distribution and culture source (>5% of total) of S. pneumoniae and H. influenzae isolates

From: Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008)

 

2004-2008

2009-2012

2004-2012

n

%

n

%

n

%

S. pneumoniae

n = 8864

n = 5574

n = 14438

Region

      

Africa

156

1.8

65

1.2

221

1.5

Asia/Pacific Rim

689

7.8

296

5.3

985

6.8

Europe

2786

31.4

2983

53.5

5769

40.0

Latin America

771

8.7

397

7.1

1168

8.1

Middle East

182

2.1

278

5.0

460

3.2

North America

4280

48.3

1555

27.9

5835

40.4

Culture source

      

Respiratory

4292

48.4

2583

46.3

6875

47.6

Cardiovascular

2614

29.5

1588

28.5

4202

29.1

HEENT

1255

14.2

861

15.4

2116

14.7

Bodily fluids

463

5.2

346

6.2

809

5.6

H. influenzae

n = 8732

n = 6038

n = 14770

Region

      

Africa

157

1.8

61

1.0

218

1.5

Asia/Pacific Rim

688

7.9

302

5.0

990

6.7

Europe

3011

34.5

3311

54.8

6322

42.8

Latin America

747

8.6

410

6.8

1157

7.8

Middle East

210

2.4

281

4.7

491

3.3

North America

3919

44.9

1673

27.7

5592

37.9

Culture source

      

Respiratory

6340

72.6

4167

69.0

10507

71.1

HEENT

1562

17.9

1163

19.3

2725

18.4

Cardiovascular

439

5.0

363

6.0

802

5.4

  1. Bodily fluids includes abscess/pus, abdominal, bile, cerebrospinal fluid, pericardial, peritoneal, pleural, synovial and tissue; Cardiovascular includes cardiovascular, blood, blood vessels and heart; HEENT includes head, ears, eyes, nose and throat; Respiratory includes respiratory, bronchial brushing, bronchials, bronchoalveolar lavage, endotracheal aspirate, lungs, sinuses, sputum and trachea.